[PLX] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -26.23%
YoY- -114.02%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 2,889 2,081 4,670 1,769 679 -11,195 5,846 -37.46%
PBT -59,148 -2,624 -7,290 -10,736 -8,526 -12,419 -3,820 520.19%
Tax 2,087 -189 268 213 314 -85,260 17 2362.88%
NP -59,148 -2,624 -7,290 -10,853 -8,598 72,900 -3,820 520.19%
Tax Rate - - - - - - - -
Total Cost 62,037 4,705 11,960 12,622 9,277 -84,095 9,666 244.96%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin -2,047.35 -126.09 -156.10 -613.51 -1,266.27 -651.18 -65.34 891.81%
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -4.75 -0.21 -0.07 -0.11 -0.09 7.31 -0.04 2308.94%
EPS Diluted -4.75 -0.21 -0.07 -0.11 -0.09 7.31 -0.04 2308.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.